PPARgamma agonists: a new strategy for antithrombotic therapy

J Thromb Haemost. 2005 Oct;3(10):2147-8. doi: 10.1111/j.1538-7836.2005.01585.x.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Diabetic Angiopathies / drug therapy*
  • Diabetic Angiopathies / etiology
  • Diabetic Angiopathies / prevention & control
  • Fibrinolytic Agents / therapeutic use*
  • Humans
  • Hyperglycemia / complications
  • Hyperglycemia / drug therapy
  • Hypoglycemic Agents / therapeutic use
  • PPAR gamma / agonists*
  • Pioglitazone
  • Platelet Activation
  • Thiazolidinediones / therapeutic use
  • Thrombosis / drug therapy*
  • Thrombosis / etiology
  • Thrombosis / prevention & control

Substances

  • Fibrinolytic Agents
  • Hypoglycemic Agents
  • PPAR gamma
  • Thiazolidinediones
  • Pioglitazone